U.S. Markets closed

Peregrine Pharmaceuticals, Inc. (PPHM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.15+0.03 (+0.96%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue57,63044,68626,781
Cost of Revenue38,25922,96615,593
Gross Profit19,37121,72011,188
Operating Expenses
Research Development28,29759,52942,996
Selling General and Administrative19,33418,55118,691
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-28,260-56,360-50,499
Income from Continuing Operations
Total Other Income/Expenses Net108722142
Earnings Before Interest and Taxes-28,152-55,638-50,357
Interest Expense7141
Income Before Tax-28,159-55,652-50,358
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-28,159-55,652-50,358
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-28,159-55,652-50,358
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-32,799-60,136-54,054